Delisting risk
Bolt Biotherapeutics (BOLT)
Develops Boltbody immune-stimulating antibody conjugates for cancer.
$3.84
At close−0.23 (−5.65%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions24 holders · as of Mar 31, 2026 | 31.84% | 613.3K shares | |
| Insiders3 holders · as of Feb 4, 2026 | 2.21% | 42.6K shares | |
| Otherremainder | 65.95% | 1.27M shares |
1.93M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
24 holders · 613.3K shares · 6 new positions · 12 increased · 3 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Sofinnova Investments, Inc. | 137.7K | 7.15% | 0 | May 15, 2026 |
| Renaissance Technologies LLC | 77.2K | 4.01% | +22.2K | May 14, 2026 |
| Vivo Capital, LLC | 72.4K | 3.76% | 0 | May 20, 2026 |
| Pivotal Bioventure Partners Investment Advisor LLC | 42.6K | 2.21% | −52.0K | May 14, 2026 |
| T3 Companies, LLC | 38.0K | 1.97% | 0 | May 7, 2026 |
| Board of Trustees of the Leland Stanford Junior University | 36.0K | 1.87% | 0 | May 7, 2026 |
| Pfizer Inc | 31.3K | 1.63% | 0 | May 12, 2026 |
| LYNX1 Capital Management LP | 30.8K | 1.60% | +30.8Knew | May 4, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tang Capital Management, LLC | 9.90% | 13G | May 15, 2025 ↗ | |
| Renaissance Technologies LLC | 5.13% | 98.6K | 13G | Aug 13, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 5, 2025 | Sarah Nemecofficer: Senior VP, Finance and PAO | Purchase | 125 | $4.61 | 1,415 |
| Dec 5, 2025 | William P. Quinndirector, officer: President, CEO and CFO | Purchase | 125 | $4.61 | 2,313 |
| Jun 6, 2025 | William P. Quinndirector, officer: President, CEO and CFO | Purchase | 125 | $5.49 | 2,188 |
| Jun 6, 2025 | Sarah Nemecofficer: Senior VP, Finance and PAO | Purchase | 125 | $5.49 | 943 |
CongressHouse and Senate disclosures
Not reported.
